Literature DB >> 2064578

Cellular and humoral anticorneal immune response in corneal transplantation.

M J Jager1, H J Völker-Dieben, A Vos, L Broersma, F G Kok, R van der Gaag.   

Abstract

Immunologic responses play a role in the rejection process of corneal transplants. Both histocompatibility antigens and tissue-specific antigens may be potential targets for such an immune response. To identify relevant responses, the humoral immune response against corneal tissue and the cellular immune response against one specific corneal protein were determined in patients before and after corneal transplantation. The results were compared with known risk factors for corneal transplantation, but no correlations were observed. A conversion from negative to positive in cellular immune response against the cornea-specific protein was seen in patients who had experienced an inflammatory episode during the time interval between measurements. The anticorneal protein response may therefore be the result of an intraocular inflammatory response, but not a prognostic factor to help predict the patients at risk for rejection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064578     DOI: 10.1001/archopht.1991.01080070084040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients.

Authors:  C S Foster; H K Wu; A Merchant
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

3.  Genetic and clinical determinants for the T cell mediated immune response against the cornea specific protein BCP 54.

Authors:  M J Jager; H J Völker-Dieben; L de Waal; F G Kok; L Broersma; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

4.  Circulating cornea-specific antibodies in corneal disease and cornea transplantation.

Authors:  M J Jager; A Vos; S Pasmans; R Hoekzema; L Broersma; R van der Gaag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-02       Impact factor: 3.117

Review 5.  Expanding Horizons in Complement Analysis and Quality Control.

Authors:  Ashley Frazer-Abel; Michael Kirschfink; Zoltán Prohászka
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.